Companies › ACET
Adicet Bio Inc (ACET)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001720580 · EDGAR filings · Updated 2026-06-23
Adicet Bio Inc (ACET) has reported institutional ownership of 67.9%, with 47 institutional managers holding positions valued at $43.2M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-06-23 — Insider transaction reported (Form 4)
- 2026-06-23 — Insider transaction reported (Form 4)
- 2026-06-23 — Insider transaction reported (Form 4)
- 2026-06-23 — Insider transaction reported (Form 4)
- 2026-06-23 — Insider transaction reported (Form 4)
- 2026-06-23 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Adicet Bio Inc has 47 institutional holders and institutional ownership of 67.9%.
Insider activity
Insiders reported 11 transactions (2 buys, 0 sells) across 10 reporting insiders, with a net reported value of $5.00M.
Data flags from SEC filings
Related companies
Oramed Pharmaceuticals Inc (ORMP) · CARTESIAN THERAPEUTICS INC (RNAC) · ATYR PHARMA INC (ATYR) · SATELLOS BIOSCIENCE INC (MSLE) · Rallybio Corp (RLYB) · GREENWICH LIFESCIENCES INC (GLSI)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-23.